Detecting Glaucomatous Progression With a Region-of-Interest Approach on Optical Coherence Tomography: A Signal-to-Noise Evaluation

利用光学相干断层扫描感兴趣区域方法检测青光眼进展:信噪比评估

阅读:1

Abstract

PURPOSE: To compare two region-of-interest (ROI) approaches and a global thickness approach for capturing progressive circumpapillary retinal nerve fiber layer (cpRNFL) changes on optical coherence tomography (OCT) imaging. METHODS: Progressive cpRNFL thickness changes were evaluated in 164 eyes with a clinical diagnosis of glaucoma or suspected glaucoma; all eyes underwent optic disc OCT imaging on two visits at least 1 year apart. Such changes were evaluated with a manual ROI approach (ROI(M)), which involved manual identification of region(s) of observed or suspected glaucomatous damage. The ROI(M) was compared with an automatic ROI approach (ROI(A)), where regions were automatically identified if the cpRNFL thickness fell below the 1% lower normative limits, and to global cpRNFL thickness. These methods were compared using longitudinal signal-to-noise ratios (SNRs), calculated based upon individualized estimates of measurement variability and age-related changes for each ROI, obtained from 321 glaucoma eyes and 394 healthy eyes, respectively. RESULTS: The average longitudinal SNR of the ROI(M), ROI(A) and global thickness methods were -0.46, -0.39, and -0.30 y(-1), respectively. The average longitudinal SNR for the ROI(M) was significantly more negative compared with both the ROI(A) and global thickness methods (P = 0.005 for both). CONCLUSIONS: A manual ROI approach was the optimal method for detecting progressive cpRNFL loss compared with an automatic ROI approach and the global cpRNFL thickness measure. TRANSLATIONAL RELEVANCE: These findings highlight the potential advantages conferred by a careful qualitative evaluation of OCT imaging for detecting glaucoma progression.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。